MedTrace Logo

LEAPTogether: An Intergenerational Intervention to Address Loneliness and Social Isolation

NCT05831475 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2024-08-22

No results posted yet for this study

Summary

Older adult participants will engage in exercise videos twice a week for 8 weeks either while paired with a peer (same age group) or paired with a younger adult with the ability to simultaneously video chat while exercising.

Conditions

  • Social Isolation
  • Loneliness
  • Intergenerational Relations

Interventions

BEHAVIORAL

Intergenerational Virtual Paired Exercise

Participants will be paired with someone older/ younger and will engage in exercise videos with the ability to simultaneously video chat with their partner while exercising. Participants will log on with their partner twice a week for 8 weeks.

BEHAVIORAL

Peer Virtual Paired Exercise

Participants will be paired with someone of the same age group and will engage in exercise videos with the ability to simultaneously video chat with their partner while exercising. Participants will log on with their partner twice a week for 8 weeks.

Sponsors & Collaborators

  • FlexTogether

    collaborator UNKNOWN

  • Cedars-Sinai Medical Center

    lead OTHER

Principal Investigators

  • Celina H Shirazipour, Ph.D. · Cedars-Sinai Medical Center

  • Allison M Mays, MD, MAS · Cedars-Sinai Medical Center

  • Sonja Rosen, MD, FACP, AGSF · Cedars-Sinai Medical Center

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-09-07
Primary Completion
2025-05-31
Completion
2025-10-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05831475 on ClinicalTrials.gov